#	Searches
1	*LYMPHOMA, B‐CELL/
2	((b‐cell adj3 lymphom*) or (b‐cell adj3 malignanc*)).tw.
3	LYMPHOMA, NON‐HODGKIN/
4	(non‐hodgkin* or non hodgkin* or nonhodgkin* or no hodgkin* or nhl).tw,kf,ot.
5	(lymph* adj2 sarcom*).tw,kf,ot.
6	lymphosarcom*.tw,kf,ot.
7	(reticulum adj2 sarcom*).tw,kf,ot.
8	(diffus* adj3 lymphom*).tw,kf,ot.
9	((lymphom* adj3 cleaved*) or (lymphom* adj3 noncleaved*) or (lymphom* adj3 non‐cleaved*) or (lymphom* adj3 grad*) or (lymphom* adj3 mixed‐cell*) or (lymphom* adj3 pleomorphic*)).tw,kf,ot.
10	reticulosarcoma*.tw,kf,ot.
11	((mixed adj3 lymphom*) or (undifferentiat* adj3 lymphom*)).tw,kf,ot.
12	NHL.tw.
13	or/1‐12
14	exp LYMPHOMA, LARGE B‐CELL, DIFFUSE/
15	(histiocyt* adj3 lymphom*).tw,kf,ot.
16	((large cell* adj3 lymphom*) or (b‐cell adj3 lymphom*) or (bcell adj3 lymphom*) or (lymphoid* adj3 lymphom*) or (histiocytic* adj3 lymphom*) or (plasmablastic* adj3 lymphom*)).tw,kf,ot.
17	DLBCL.tw,kf,ot.
18	or/14‐17
19	13 or 18
20	IMMUNOTHERAPY, ADOPTIVE/
21	(immunotherap* adj3 adoptiv*).tw,kf,ot,nm.
22	((t‐cell* adj1 therap*) or (tcell* adj1 therap*)).tw.
23	or/20‐22
24	RECEPTORS, CHIMERIC ANTIGEN/
25	((chimeric* adj3 antigen receptor*) or (chimeric* adj3 immunoreceptor*) or (chimeric* adj3 T cell receptor*) or (chimeric* adj3 Tcell receptor*)).tw,kf,ot,nm.
26	((artificial* adj3 T cell receptor*) or (artificial* adj3 Tcell receptor*)).tw,kf,ot,nm.
27	or/24‐26
28	axicabtagene*.tw,kf,ot,nm.
29	(yescarta* or axi‐cel* or KTE‐C19 or "CTL 019").tw,kf,ot.
30	or/28‐29
31	tisagenlecleucel*.tw,kf,ot.
32	kymriah*.tw,kf,ot,nm.
33	or/31‐32
34	Lisocabtagene*.tw,kf,ot.
35	JCAR017*.tw,kf,ot.
36	liso‐cel*.tw,kf,ot.
37	or/34‐36
38	23 or 27 or 30 or 33 or 37
39	19 and 38
40	exp animals/ not humans/
41	39 not 40
42	(CD30* or anti‐CD30* or antiCD‐30* or CART30*).tw,kf,ot,nm.
43	(antigen* adj3 ber h2).tw,kf,ot,nm.
44	TNFRSF8*.tw,kf,ot,nm.
45	(tumor necrosis factor receptor* adj3 member 8).tw,kf,ot.
46	or/40‐45
47	Sialic Acid Binding Ig‐like Lectin 2/
48	(CD22* or anti‐CD22* or antiCD22* or CART22*).tw.
49	b lymphocyte cell adhesion molecul*.tw.
50	siglec‐2*.tw.
51	or/47‐50
52	23 or 29 or 33 or 36 or 39 or 46 or 51
53	19 and 52
54	randomized controlled trial.pt.
55	controlled clinical trial.pt.
56	randomi?ed.ab.
57	placebo.ab.
58	drug therapy.fs.
59	randomly.ab.
60	trial.ab.
61	groups.ab.
62	or/54‐61
63	humans.sh.
64	62 and 63
65	exp Cohort Studies/
66	cohort*.tw.
67	controlled clinical trial.pt.
68	Epidemiologic Methods/
69	limit 68 to yr=1966‐1989
70	exp case‐control studies/
71	(case* and control*).tw.
72	(case* and series).tw.
73	case reports.pt.
74	(case* adj2 report*).tw.
75	(case* adj2 stud*).tw.
76	65 or 66 or 67 or 69 or 70 or 71 or 72 or 73 or 74 or 75
77	53 and 64
78	53 and 76
79	77 or 78